Ben Pais

Company: Nuclidium

Job title: CMO

Seminars:

Designing Optimal First in Human Radiopharmaceutical Trials for Translational Success: Regulatory Considerations 2:00 pm

First-in-human radiopharmaceutical trials are critical for assessing the safety, pharmacokinetics, dosimetry, and preliminary efficacy of new radiopharmaceuticals. The design of these trials must be meticulous to ensure patient safety while gathering essential data. Key components include patient monitoring duration, dose toxicity assessment, and primary readouts. Join this workshop to: Uncover pre, during and post-treatment monitoring…Read more

day: Workshop C